FDA Inspection
Takeda Pharmaceutical Company LimitedTakeda Pharmaceutical Company Limited – FDA Inspection, May 24, 2023
Record Details
This FDA Inspection record concerns Takeda Pharmaceutical Company Limited, with an inspection on May 24, 2023, issued by the Office of Inspections and Investigations.
- Inspection Date
- May 24, 2023
View Company Profile
ID · cdd33b98-5693-473b-a7f6-dbe8d234604d
Inspection Facts
- Inspection number
- 1218059
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Takeda Pharmaceutical Company Limited
9| Date | Classification | Office | Project area |
|---|---|---|---|
| November 6, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 19, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 26, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 7, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 30, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Takeda Pharmaceutical Company Limited
- FDA Inspection 1224917 - 2023-11-06
- FDA Inspection 1148832 - 2021-07-19
- FDA Inspection 1111495 - 2019-11-26
- FDA Inspection 1033814 - 2017-11-07
- FDA Inspection 951603 - 2015-10-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.